PACS CEO Jason Hulse Murray Sells $77K of Stock

PACS Group, Inc. Co-Founder, CEO and Chairman Jason Hulse Murray sold 1,620 shares of stock on October 19, 2026, according to a Form 4 filed with the Securities and Exchange Commission.

PACS PACS Group, Inc.

$47.43 ▲ +20.05% year to date

1M 3M YTD

Daily close · Oct 21, 2026

Inside Jason Hulse Murray's PACS Group Trade

The Chief Executive sold the shares at an average price of $47.57, bringing the total transaction value to $77,059.67. The sale was executed under a pre-arranged Rule 10b5-1 trading plan. Following the transaction, the CEO held 54,314,900 shares directly. This transaction follows earlier sales by Murray in October, including 110,035 shares sold on October 15 and 8,462 shares sold on October 16.

Other Institutional Activity in PACS Group, Inc.

Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending with 8,343,381 shares worth about $390.1 million. Crewe Advisors LLC grew its holdings by 553,034 shares, ending with 3,307,188 shares worth about $154.6 million. American Century Companies Inc added 1,298,580 shares for a 71.8% increase, finishing with 3,108,196 shares valued at about $145.3 million. Ameriprise Financial, Inc. grew its stake by 873,697 shares to reach 1,995,116 shares worth about $93.3 million. Meanwhile, Alyeska Investment Group, L.P. cut its stake by 1,463,403 shares, holding 1,539,065 shares worth about $72.0 million as of June 30, 2026.

PACS Group, Inc. Stock Holds Steady

The stock recently traded around $47.72 as of October 21, 2026. On the day of the insider trade, PACS Group closed at $45.85.

Recent Earnings

PACS Group, Inc. reported trailing twelve-month revenue of $5.55 billion and an earnings per share of $1.71. The company's next earnings release is scheduled for November 9, 2026.

Insider Buying and Selling at PACS Group, Inc.

Company insiders have been active recently. Co-Founder and Executive Vice Chair Mark Hancock sold 138,069 shares on June 25, 2026, for about $5.57 million. President and COO Joshua Jergensen sold 40,000 shares on October 14, 2026, for about $1.78 million.

Analysts Set New Price Targets

UBS maintains a Buy rating with a target of $60.00 as of August 6, 2026. RBC Capital maintains an Outperform rating with a $57.00 target, and Truist Securities maintains a Buy rating with a target of $62.00. Oppenheimer maintains an Outperform rating with a $57.00 target, while JP Morgan maintains an Overweight rating with a $58.00 target. The stock holds a consensus strong buy rating and a mean price target of $59.00 across six analyst opinions.

About PACS Group, Inc.

PACS Group, Inc., headquartered in Salt Lake City, Utah, operates skilled nursing facilities, assisted living facilities, and senior care properties across the United States. Founded in 2013, the healthcare company manages a large portfolio of care facilities and health care-related properties.

Bottom Line

Investors will watch the upcoming earnings report on November 9, 2026, for further updates on financial performance. Future SEC filings will reveal whether insiders continue to adjust their holdings.